Eskİer Doğa, Akalp Evren, Dalan Özlem, KarakÜlah Gökhan, Oktay Yavuz
İzmir Biomedicine and Genome Center (IBG), İzmir Turkey.
İzmir International Biomedicine and Genome Institute (iBG-İzmir), Dokuz Eylül University, İzmir Turkey.
Turk J Biol. 2021 Feb 9;45(1):104-113. doi: 10.3906/biy-2008-56. eCollection 2021.
As the underlying pathogen for the COVID-19 pandemic that has affected tens of millions of lives worldwide, SARS-CoV-2 and its mutations are among the most urgent research topics worldwide. Mutations in the virus genome can complicate attempts at accurate testing or developing a working treatment for the disease. Furthermore, because the virus uses its own proteins to replicate its genome, rather than host proteins, mutations in the replication proteins can have cascading effects on the mutation load of the virus genome. Due to the global, rapidly developing nature of the COVID-19 pandemic, local demographics of the virus can be difficult to accurately analyze and track, disproportionate to the importance of such information. Here, we analyzed available, high-quality genome data of SARS-CoV-2 isolates from Turkey and identified their mutations, in comparison to the reference genome, to understand how the local mutatome compares to the global genomes. Our results indicate that viral genomes in Turkey has one of the highest mutation loads and certain mutations are remarkably frequent compared to global genomes. We also made the data on Turkey isolates available on an online database to facilitate further research on SARS-CoV-2 mutations in Turkey.
作为这场影响了全球数千万人生命的新冠疫情的潜在病原体,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其突变是全球最紧迫的研究课题之一。病毒基因组中的突变会使准确检测或研发有效治疗该疾病的尝试变得复杂。此外,由于该病毒利用自身蛋白质而非宿主蛋白质来复制其基因组,复制蛋白中的突变会对病毒基因组的突变负荷产生连锁反应。鉴于新冠疫情的全球性和快速发展的特性,病毒的本地人口统计学特征可能难以准确分析和追踪,而这些信息的重要性却不成比例。在此,我们分析了来自土耳其的SARS-CoV-2分离株的可用高质量基因组数据,并与参考基因组相比确定了它们的突变,以了解本地突变组与全球基因组的差异。我们的结果表明,土耳其的病毒基因组具有最高的突变负荷之一,与全球基因组相比,某些突变非常频繁。我们还将土耳其分离株的数据发布在一个在线数据库上,以促进对土耳其SARS-CoV-2突变的进一步研究。
Turk J Biol. 2021-2-9
Elife. 2022-11-15
Transbound Emerg Dis. 2021-11
Turk J Biol. 2020-6-21
Turk J Biol. 2020-6-21
Genomics. 2020-4-27
J Biol Regul Homeost Agents. 2021
Hum Vaccin Immunother. 2023-8-1
Turk J Med Sci. 2023-2
Turk J Biol. 2021-8-30
Lancet Infect Dis. 2021-1
Am J Respir Crit Care Med. 2020-12-1
PeerJ. 2020-7-21